MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 17, 2025

Date Posted: July 3, 2025

The following Local Coverage Determinations (LCDs) have completed the Open Public Meeting comment period and are now finalized under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Medicare Coverage Database Number MolDX LCD Title
L39946 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
L39950 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
L39927 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
MCD Number MolDX Billing and Coding Article Title
A59870 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease
A59874 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A59837 Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Medicare Coverage Database Number Response to Comments
A60207 Response to comments: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease
A60202 Response to comments: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A60228 Response to Comments: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms

Effective Date: August 17, 2025

View Active MolDX LCDs on our website or the CMS MCD.

Last Updated Jul 03 , 2025